In 1966, two Brazilian men were found dead on Vintém Hill under bizarre circumstances that continue to perplex investigators and conspiracy theorists alike. Lying side by side, their bodies were discovered wearing matching lead masks—shields with no eyeholes—alongside cryptic notes. Were they victims of a cult ritual, a failed experiment, or something even more otherworldly? See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info .…
Player FM - Internet Radio Done Right
Checked 1y ago
추가했습니다 one 년 전
Prashant Jambunathan에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Prashant Jambunathan 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
))
Daily Deals
Oncology On Air
모두 재생(하지 않음)으로 표시
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 27, 2024 09:12 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage series 3540536
Prashant Jambunathan에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Prashant Jambunathan 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology.
Contact
prashant.jambunathan@gmail.com
22 에피소드
공유
모두 재생(하지 않음)으로 표시
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 27, 2024 09:12 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage series 3540536
Prashant Jambunathan에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Prashant Jambunathan 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology.
Contact
prashant.jambunathan@gmail.com
22 에피소드
모든 에피소드
×
O
Oncology On Air
1 Ep. 22 Recent advances in management of testicular germ cell tumours 20:55
20:55 
나중에 재생 
나중에 재생 
리스트 
좋아요 
좋아요20:55
나중에 재생 나중에 재생 리스트 좋아요 좋아요In this episode, we will discuss, in brief the recent changes to the IGCCCG risk classification as well as recent advances in the management of germ cell tumours, beyond TIP. The role of miRNA in prognostication, as well the role of Brentuximab vedotin, guadecitabine and other newer molecules is explored.…
O
Oncology On Air
1 Ep. 21 Recent advances in management of advanced upper GI cancers: targeted biologic therapies 9:25
9:25 나중에 재생 나중에 재생 리스트 좋아요 좋아요9:25
나중에 재생 나중에 재생 리스트 좋아요 좋아요In this brief episode, we will talk about emerging data for the anti CLAUDIN 18.2 monoclonal antibody Zolbetuximab, in the MONO, GLOW and SPOTLIGHT trials. for advanced, unresectable or metastatic, HER2 negative gastric or GE junction adenocarcinomas.
O
Oncology On Air
1 Ep. 20 Recent advances in management of advanced upper GI cancers: Immunotherapy 12:24
12:24 나중에 재생 나중에 재생 리스트 좋아요 좋아요12:24
나중에 재생 나중에 재생 리스트 좋아요 좋아요In the first part of this two part episode, we will talk about the role of Pembrolizumab (Keynote 062 for first line, Keynote 181 for second line) and Nivolumab (Checkmate 849) in both, first and later lines, in the management of advanced HER2 negative, gastric and GE junction cancers.
O
Oncology On Air
We will discuss the emerging treatment landscape of Neuroblastoma, beyond Dinutuximab. We begin with Naxitamab, followed by the role of ALK inhibitors like Ceritinib and Crizotinib. We then move on to AURORA inhibitors, and other newer treatment modalities in phase 1 and 2 clinical trials.
O
Oncology On Air
1 Ep. 18 Neuroblastoma: molecular and clinical features, staging and first line treatment 14:45
14:45 나중에 재생 나중에 재생 리스트 좋아요 좋아요14:45
나중에 재생 나중에 재생 리스트 좋아요 좋아요We will delve into Neuroblastoma in this episode, which is the most common extra-cranial solid tumour diagnosed in children. We will begin with a discussion of the clinical features, INRG staging, molecular features and prognostic factors. Treatment for all risk groups, including the COJEC chemotherapy based induction for high risk forms part of the discussion.…
O
Oncology On Air
This is part 2 of our two episode series on Peripheral T cell lymphomas. We will talk about the aggressive variants, which includes T cell lymphoma/leukemia, Systemic anaplastic large cell lymphoma and others. Disease biology, clinical presentations and treatment options are covered, with a brief discussion on newer treatment options.…
O
Oncology On Air
In the first part of this two part episode, we will talk the indolent peripheral T cell lymphomas, which include Mycosis fungicides, cutaneous ALCL and T cell large granular lymphocytic leukaemia. Clinical features, immunophenotyping and treatment options form the mainstay of the discussion.
O
Oncology On Air
In this episode we will talk about the varied treatment landscape of MCL, ranging from Bendamustine - Rituximab and alternating RCHOP/RDHAP to the Nordic regimen. We will begin with a brief description of the clinical and immunophenotypical characteristics of MCL, followed by discussion of treatment in fit, as well as, older patients.…
O
Oncology On Air
1 Ep. 14 Non Hodgkin's lymphoma: Immunodeficiency associated and post-transplant lymphoproliferative disorders 10:37
10:37 나중에 재생 나중에 재생 리스트 좋아요 좋아요10:37
나중에 재생 나중에 재생 리스트 좋아요 좋아요We begin with the WHO classification of the Immunodeficiency associated lymphoproliferative disorders followed by a brief discussion of the management of HIV associated and post-transplant lymphoproliferative disorders.
O
Oncology On Air
Starting with disease biology, clinical features and evaluation, we will discuss the management of Primary and secondary CNS lymphoma and Burkitt lymphoma, in this episode.
O
Oncology On Air
1 Ep. 12 Non Hodgkin's lymphoma: PMBCL, double hit lymphoma and grey zone lymphomas 9:52
9:52 나중에 재생 나중에 재생 리스트 좋아요 좋아요9:52
나중에 재생 나중에 재생 리스트 좋아요 좋아요We will talk about Primary Mediastinal B cell lymphoma, double hit lymphomas, GZL and T cell histiocyte rich diffuse large B cell lymphoma in this episode. Clinical features, immunophenotypic features and treatment options with prognosis are discussed.
O
Oncology On Air
1 Ep. 11 Non Hodgkin's lymphoma: Diffuse large B cell lymphoma - Part 1 27:35
27:35 나중에 재생 나중에 재생 리스트 좋아요 좋아요27:35
나중에 재생 나중에 재생 리스트 좋아요 좋아요In the first part of this this two part episode, we will talk about the management strategies for early as well as advanced DLBCL. We will delve into the GCB and ABC subtypes, and discuss how RCHOP evolved as the standard of care of DLBCL. Second line salvage regimens, newer treatments, including a brief overview of CAR-T cell therapy is also discussed.…
O
Oncology On Air
In this episode we will continue our deliberation on indolent NHL, with the WHO classification of Marginal Zone Lymphoma and the management of the various subtypes. We will explore the role of Rituximab, Bendamustine, Ibrutinib, as well as the role of splenectomy in splenic MZL.
O
Oncology On Air
In this episode we will discuss the prototypical indolent lymphoma, with a brief discussion on grades, followed by management strategies in low tumour and high tumour burden settings. In addition to using Bendamustine and Rituximab, the question of whether to use Obinituzumab in the first line, as well as, the role of maintenance anti-CD20 are also deliberated upon. Newer treatment strategies such as Lenalidomide, Idelalisib, Copanlisib, Duvelisib are also included.…
O
Oncology On Air
1 Ep. 8 Non Hodgkin's lymphoma: Clinical features, staging and prognostic factors 17:38
17:38 나중에 재생 나중에 재생 리스트 좋아요 좋아요17:38
나중에 재생 나중에 재생 리스트 좋아요 좋아요The clinical features, staging with Lugano system, the Deauville scoring system, as well as, prognostication with the International Prognostic index, Follicular lymphoma International prognostic index and the Lugano response criteria, on PET CT, forms the basis for this episode.
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.
Daily Deals
Daily Deals
Daily Deals
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
))
